Nicholas Arnold, MD
Orthopaedic Surgery · Fort Wayne, INNPI 1326400771
Payments from drug & device makers
Across 68 payments — averaging $165.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UOC USA Inc$5K
- Stryker$2K
- Ortho Development Corporation$2K
- Zimmer Biomet$772
- Maxx Orthopedics, Inc.$423
- Hikma Pharmaceuticals USA$423
- plus $526 from 4 others
What the payments were for
- Consulting fees$4,50340%
- Travel & lodging$2,98426%
- Food & beverage$3,79634%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UOC USA Inc | 7 | $4,652 |
| Stryker | 31 | $2,409 |
| Ortho Development Corporation | 11 | $2,077 |
| Zimmer Biomet | 8 | $772 |
| Maxx Orthopedics, Inc. | 3 | $423 |
| Hikma Pharmaceuticals USA | 1 | $423 |
| Johnson & Johnson | 3 | $234 |
| Medtronic | 1 | $129 |
| Smith+Nephew | 1 | $104 |
| Medical Device Business Services, Inc. | 2 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- U2 PF+$4,224
- MAKO$1,451
- BKS TriMax$1,367
- Entrada Hip Stem$1,263
- COMBOGESIC IV$423
- Balance Knee Revision System$340
- INSIGNIA$304
- ACCOLADE$156
- Persona$131
- AQUAMANTYS$129
- ROSA$129
- NA$123
- TFN-Advance$123
- U2$115
- U2, Conformity, U-Motion II, PSA, U-Star II$106
- USTAR II$106
- OR3O Dual Mobility$104
- TRIATHLON$102
How this compares
$11,283 in reported general payments places this provider in the 65th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $4,996 |
| Oxycodone Hcl | 175 | $992 |
| Methocarbamol | 113 | $952 |
| Doxycycline Hyclate | 22 | $759 |
| Tramadol Hcl | 211 | $560 |
| Cefadroxil | 68 | $442 |
| Doxycycline Monohydrate | 17 | $314 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $191 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $147 |
| Cyclobenzaprine Hcl | 14 | $136 |
| Meloxicam | 55 | $90 |
| Clindamycin Hcl | 60 | $64 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Fort Wayne
- John WilliamsFort Wayne$2.7M
- Alan McGeeFort Wayne$2.3M
- Micah SmithFort Wayne$1.2M
- Ian NelsonFort Wayne$515K
- Michael LeeFort Wayne$202K
- Alan McGeeFort Wayne$135K
- Christopher JohnsonFort Wayne$98K
- Brandon HugginsFort Wayne$87K
- Frank KolisekGreenwood$7.6M
- David FisherIndianapolis$5.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.